Nanoplastics (NP) and microplastics (MP) accumulate in our environment as a consequence of the massive consumption of plastics. Huge knowledge-gaps exist regarding uptake and fate of plastic particles in micro-and nano-dimensions in humans as well as on their impact on human health.
accidental inputs, littering, illegal dumping and coastal human activities (Avio et al., 2017; Wang et al., 2016; Waring et al., 2018) . Microparticles were not only found in the ocean (Avio et al., 2017; Gall and Thompson, 2015) . They are also present in lakes (Fischer et al., 2016; Klein et al., 2015; Lechner et al., 2014; W. Wang et al., 2017) , and in Arctic sea ice of up to 12.000 particles per cubic meter (Kanhai et al., 2017; Lusher et al., 2015; Suaria et al., 2016; Woodall et al., 2014) . Therefore, the EU Commission is considering a ban on MP in cosmetics, personal care, detergents and cleaning agents by 2020, so that in future dermal exposure can be neglected. Also, a strategy against plastic waste in the seas was presented by the EU at the end of May 2018 (European Commission, 2018) . The persistence of plastic materials leads to their accumulations in so-called "garbage patches" in the oceans (Law and Thompson, 2014) . This marine litter is a significant threat to the entire ecosystem since the ingestion and entanglement of macro-plastics end up in death for many marine species. But also human health is at risk. MP have already been determined in numerous foods, such as fish (Bessa et al., 2018; Davidson and Dudas, 2016; Hermsen et al., 2017; Rummel et al., 2016) , shrimp (Bessa et al., 2018) , sardines (Karami et al., 2018) , and mussels (Auta et al., 2017; EFSA, 2016; Van Cauwenberghe et al., 2015; Van Cauwenberghe and Janssen, 2014) . MP were also detected in sea salt (Iñiguez et al., 2017; Karami et al., 2017; Yang et al., 2015) , honey and sugar (Liebezeit and Liebezeit, 2013) , beer (Kosuth et al., 2018; Liebezeit and Liebezeit, 2014) or tap water (Kosuth et al., 2018) . Investigations of drinking water showed low levels of MP contamination (0.4-7 particles/m³) (Mintenig et al., 2014) . MP accumulate in the ground water (Holm et al., 2013; Lusher et al., 2017; Pörschke and Eloo, 2016) because it is not possible to filter all particles in sewage treatment plants due to their broad size range (<0.1-5000 µm). In addition to oral exposure, humans may also inhale airborne MPs (e.g., MP from car tire abrasion).
It is known that MP has numerous adverse effects on the ecosystem and environmental organisms (Huerta Lwanga et al., 2017; Luís et al., 2015; Rodriguez-Seijo et al., 2017; Watts et al., 2016 Watts et al., , 2015 , which classifies it as an environmental pollutant .
MP in various sizes (nano and micron size) can trigger different harmful effects in aquatic organisms including direct physical damage (tissue damage, accumulation, inflammation) and toxicity related to oxidative stress (Canesi et al., 2015; Sun et al., 2018) . Effects caused from the release of pollutants which are deposited on the MP and are absorbed into the organisms are possible (Browne et al., 2013; Lusher et al., 2017; von Moos et al., 2012; Welden and Cowie, 2016; Wright and Kelly, 2017) . Not only in aquatic, but also other organisms such as the mosquito (Culex mosquito), uptake and storage of the MP in the tissue was identified . Environmental pollutants often persist not only in the environment, but can also be transferred to humans.
Against this background, there is an urgent need for the human risk assessment of NP and MP. Until today only a limited number of studies exist on the absorption and transport behavior of NP or MP in the human body (EFSA, 2016; Lusher et al., 2017; Revel et al., 2018) . NP and MP most likely enter the human organism via the food chain or through contamination of the respiratory air (Hussain et al., 2001; Lusher et al., 2017; Prata, 2018; Revel et al., 2018; Wright and Kelly, 2017) . Since previous research has focused mainly on the aquatic environment, there are only few studies available on the contamination of terrestrial areas and the effect of MP in terrestrial animals and organisms at the end of the food web (Awet et al., 2018; Cuthbert et al., 2019; de Souza Machado et al., 2018; Huerta Lwanga et al., 2017) .
A decisive factor for the uptake in the organism is the particle size. Particles < 150 μm can potentially be absorbed through the intestinal mucosa and pass to the lymphatic system, particles < 110 μm can enter the bloodstream through the portal vein and particles < 20 μm can reach internal organs (EFSA., 2016; Schmidt et al., 2013; Smith et al., 2018; Wright and Kelly, 2017) . However, most of the orally ingested nanoparticles pass the gastrointestinal tract (GIT) without being absorbed over the GIT barrier (Kreyling et al., 2017) . If passing the intestinal barrier, particles < 100 nm can even be transported into the brain (Barboza et al., 2018; Betzer et al., 2017; Wright and Kelly, 2017) and across the placental barrier (Barboza et al., 2018; Betzer et al., 2017; Bouwmeester et al., 2015; Wick et al., 2010) . Inhaled particles can be excreted by mucociliary clearance, but can also settle in the lungs or be absorbed into the bloodstream (Prata, 2018; Wright and Kelly, 2017) . One hazard caused by MP is the formation of lesions and inflammations in the tissue. Oxidative stress, necrosis, and DNA damage can also be triggered (Lehner et al., 2019; Lusher et al., 2017) . The few data which currently exist are contradictory, as there are also studies published, demonstrating that PSnano-and -microparticles do not induce toxic effects (Ašmonaitė et al., 2018; Fröhlich et al., 2012; Loos et al., 2014; Wang et al., 2019) .
Studies with polymeric particles applied as drug delivery systems showed cellular uptake of the particles in the human in vitro models Caco-2 and MDCK (Kulkarni and Feng, 2013) as well as the biodistribution in vivo (Hussain et al., 2001; Schmidt et al., 2013) . But, very little is known about the toxicity caused by plastic particles following their uptake and the effect on human health. One in vitro study describes the induction of oxidative stress after the exposure with PS-nano-and microparticles at a concentration of 10 mg/L to cerebral and epithelial human cells (Schirinzi et al., 2017) . There is an ongoing discussion on human health effects induced by plastic particles because too many questions are still open (Barboza et al., 2018) .
For this reason, in this study, the interaction and the translocation of PS-nanoparticles (50 nm) and PS-microparticles (0.5 µm) as representatives for NP and MP, were investigated in different biological models in vitro. PS is known as Styropor and used as insulation and packaging material. It is also used in various areas of daily use, e.g., in food packaging, and thus frequently comes into contact with the human organism. In this study two biological barriers were chosen to investigate the translocation and the intracellular distribution: the GI tract, as the most likely entry port of MP and NP and the placental barrier, covering the most vulnerable subpopulation, the fetus. To consider the toxic potential of PS-NP and -MP for the embryo, the embryonic stem cell test was performed as one sensitive endpoint of our multiendpoint study. As the DNA damaging potential of NP and MP on human cells is an open question so far, genotoxicological investigations were performed additionally. In contrast to single-organ studies, the analysis of these multiple endpoints will provide a consistent dataset to compare organ-specific outcomes. This study is an essential contribution to the toxicological assessment of PS nano-and microparticles. 7
Materials and Methods

Synthesis and functionalization of the PS particles
PS nanoparticles were synthesized via emulsion polymerisation with styrene, acrylic acid, divinylbenzene as a cross-linker, sodium-dodecylbenzenesulfonate as stabiliser and rhodamine 6G as fluorescence marker as previously described (Awet et al., 2018) . For surface functionalization acrylic acid was added to the reaction mixture, resulting in a carboxy-modified surface (PS-COOH). For PS microparticles, commercially available PS particles functionalized with carboxylic surface-groups have been used (PS-COOH-L2867, Microparticles GmbH, Berlin, Germany) introducing the fluorescence marker rhodamine 6G after activation with 1-Ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC). To evaluate the particle surface coverage with carboxylic groups, a titration with 0.01 M NaOH / 0.1 M NaCl was performed, controlled by a pH-measuring system.
Transmission electron microscopy (TEM)
Transmission electron microscopy (TEM) was conducted to characterize the particle size and shape. The particles were prepared by treating the stock suspensions in an ultrasonic bath for 15 min at 42 W/L. The suspensions were diluted to a concentration of 10 µg/mL with water (HiPerSolv CHROMANORM® for HPLC). 2 µL were transferred to single slot grids, dried overnight and imaged in a Philips CM 12 Transmissions Electron Microscope at 80 kV. For the determination of NP and MP size, 100 particles each were measured.
Characterization of PS-nano and PS-micro and detection of particle translocation by asymmetrical flow field-flow fractionation (AF4)
Applied fractionation system: The samples were separated and analyzed using an asymmetrical flow field-flow fractionation system (AF4) (AF2000, Postnova Analytics GmbH, Landsberg am Lech, Germany). The system was equipped with an autosampler (PN5300), channel thermostat (PN4020), UV (PN3211) and Multi-Angle Light Scattering MALS (PN3621, 8 21 angles) detectors as well as a Smart Stream Splitter (PN1650). A channel with a tip to tip length of 277 mm, a Mylar spacer with a thickness of 350 µm and a regenerated cellulose membrane with a cut-off of 100 kDa was used for all measurements. The UV detection was conducted at a wavelength of 254 nm, and the MALS detector provided the gyration radius (calculated using the sphere model). The thermostat was set to 25 °C to stabilize the channel temperature. The autosampler temperature was kept constant at 10 °C. The data acquisition and MALS calculations were performed within the AF2000 Control Unit software (Postnova Analytics GmbH, Landsberg am Lech, Germany). The radius of gyration was evaluated with 17 active angles (20° to 148°). Spherical geometrical diameters (Dgeo) were calculated from the diameter of gyration (Dg) based on the following relationship
The MALS angles were normalized with respect to the 90° angle based on a scattering form factor for spheres using a fractionation measurement of a 60 nm PS-nano size standard.
Applied carrier solution: Ultrapure water (UPW) was prepared using a Milli-Q integral 5
Millipore system (EMD Merck Millipore, MA, USA), with subsequent vacuum filtration through a 0.1 µm pore membrane (Durapore, Merck Millipore, Ireland Applied fractionation methods: The focusing step was performed with an injection flow of 0.2 mL min -1 and 7 min injection time. The elution profile for the PS-nano consisted of a 7 min constant cross flow at 1 mL min -1 , followed by 40 min of an exponentially decreasing cross flow, continuing with 15 min of a cross flow of 0.1 mL min -1 . A rinse step of 22 min was applied to check potential particle release and to ensure reproducible measurements.
For the PS-micro an initial cross flow of 0.5 mL min -1 was kept constant for 7 min. The cross flow was then decreased to 0.1 mL min -1 in 30 min by an exponential decay and kept constant at 0.1 mL min -1 for another 20 min. Afterwards, a rinse step of 17 min was applied to flush the system.
Above described methods were applied for both characterizing the native PS-particle suspensions in the different cell culture media as well as the samples obtained from the translocation studies. However, while for the characterization of the native PS-particle suspensions UV-and MALS-detection was used, only UV-detection was applied to determine respective PS-particle sizes.
The basolateral samples from the translocation studies were measured as received; the apical samples were diluted with UPW up to a factor of 30 to have a sufficient injection volume and concentration for AF4-UV-MALS measurements.
Determination of the limit of detection and limit of quantification of the AF4 system: Limit of detection (LOD) and quantification (LOQ) were determined for AF4-UV-measurements based on the three and ten sigma, 3σ and 10σ, criterion respectively. Therefore, the sensitivity of the UV signal towards the PS particles was evaluated with duplicate measurements of three different concentrations. The noise for both particle-media suspensions was calculated from at least three blank measurements by determining the standard deviation of the noise. For all measurements, 60 % of the detector flow was split in order to enhance the sensitivity of the AF4-UV-MALS system.
ζ-potential measurements
For zeta potential measurements, 10 µL of the particle stock solution were added to 990 µL of cell culture medium and transferred to folded capillary cells (DTS1070, Malvern Panalytical, Malvern, United Kingdom). Electrophoretic mobility was measured by laser Doppler Microelectropheresis at 25 °C, three times with 10 to 100 subruns (Zetasizer NanoZS, Malvern Panalytical, Malvern, United Kingdom) and the zeta potential was calculated by Zetasizer NanoZS software.
Cell Culture
Caco-2, a human adenocarcinoma cell line with epithelial morphology, was obtained from DSMZ (Deutsche Sammlung für Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany). HT29-MTX-E12, a mucus-secreting subclone from colon adenocarcinoma HT29 cells, differentiated into mature goblet cells by methotrexate, was obtained from Sigma-Aldrich penicillin G (100 U/mL). All cell lines were cultivated in a humidified incubator at 37 °C with 5 % CO2 atmosphere and were passaged twice a week.
Cell viability assays
For the determination of the viability of the GIT co-culture model, Caco-2 and HT29-MTX-E12 cells were seeded in a ratio of 90:10 (1x 10 4 cells per well; three replicates were done per condition and experiment) on Transwell ® inserts (pore size of 3.0 µm, growth area of 1.12 cm², Corning, USA). On day 21 of Caco-2/HT29-MTX-E12-culture, the particles were applied to the cells in a concentration range from 0.1 to 100 µg/mL for 24 h. Afterwards cell viability was determined via WST-1 cell proliferation reagent (Roche, Germany) according to the manufacturer's operating instruction. The absorption was determined at 450 nm (reference wavelength 690 nm), and the values were blank-corrected. Viability of the control (cells exposed to particle-free medium) was set to 100 %.
The influence of the PS particles on BeWo cell viability was assessed using the MTS assay.
Cells were seeded in a 96-well plate (1x 10 4 cells per well; three replicates were done per condition and experiment) for 24 h and subsequently treated with different concentrations of the PS particles. As negative control, cells without treatment were used. After incubation (24 h) at 37 °C and 5 % CO2, the MTS assay (CellTiter96® AQueous One Solution Cell Proliferation Assay, Promega, Dübendorf, Switzerland) was performed according to the manufacturer's instructions. Optical density was measured at 490 nm with a microplate reader (Mithras2 LB 943, Berthold Technologies GmbH, Zug, Switzerland). OD values were blank-corrected and normalized to untreated controls. Potential interference of the PS particles with the MTS assay was excluded beforehand.
To assess PS particle toxicity on mES-D3 and NIH/3T3 cells in 2D, cell suspensions of NIH/3T3 and mES-D3-cells were prepared in growth media (1x10 4 cells/mL) and were transferred to 0.1 % gelatin-coated 96-well cell culture plates (50 µL/well). All peripheral wells of the assay plate were filled with 200 µL growth media. A 7-point dilution series in growth media was prepared for each test compound and was transferred to the assay plate 2 h after cell seeding (150 µL/well). Afterwards, the cells were incubated in humidified atmosphere at 37 °C and 5 % CO2. Three and five days after seeding the cell supernatant was replaced by freshly prepared PS particle solution (200 µL/well). Seven days after seeding the assay plate was taken out of the incubator and located at room temperature for 10 min, before cell supernatant was aspirated (80 µL/well) and CellTiter-Glo reagent (Promega, Inc.) were dispensed (50 µL/well). Afterwards, the assay plate was placed on a shaker for 1 min. After 10 min incubation at room temperature, the luminescence signal was detected on an EnVision plate reader (PerkinElmer Inc.).
Mouse ES-D3 differentiation assay in hanging drop
The mES-D3 differentiation assay was performed according to Seiler and Spielmann, 2011 To predict embryotoxic potential, the prediction model (PM) originally proposed by Seiler and Spielmann, 2011 for the EST was refined using data obtained during a prevalidation study.
Basically, for the improved prediction model (iPM), the endpoints were not changed, except that IC50 and ID50 concentrations above 1000 µg/mL are not calculated. If IC50 or DC50 value exceeds this concentration, it is set to 1000 µg/mL by definition, which implies that for future testing, the maximum test concentration will be 1000 µg/mL. ln the iPM, the combination of endpoints, which were applied as variants in the previous linear discriminant analysis, have been modified:
Function I: 5.92*lg(IC50 3T3)+3.5*lg(IC50 mESC)-5.31*(IC50 3T3-ID50)/IC50 3T3-15.7
Function II: 3.65*lg(IC50 3T3)+2.39*lg(IC50 mESC)-2.03*(IC50 3T3-ID50)/IC50 3T3-6.85
Function III: -0.125*lg(IC50 3T3)-1.92*lg(IC50 mESC)+1.5*(IC50 3T3-ID50)/ IC50 3T3-2.67
The classification was based on the following criteria. Non-embryotoxic particles comply with the following rule function I > function II and function I > function III, weakly embryotoxic particles show function II > function I and function II > function III and strongly embryotoxic particles comply to the rule function III > function I and function III > function II.
In vitro translocation studies
For transport studies of the particles through the biological barriers, cells were seeded on polycarbonate Transwell ® inserts (pore size 3.0 µm, growth area 1.12 cm 2 , apical volume 0.5 mL, basolateral volume 1.5 mL; Corning ® , Sigma-Aldrich, Buchs, Switzerland). Caco-2 and HT29-MTX-E12 cells were seeded in a ratio of 90:10 at a density of 1.0 x10 5 cells per well on inserts and cultured for 21 days with medium exchange every second day. BeWo b30/HPEC-A2 co-cultures were performed as described previously (Aengenheister et al., 2018) . Briefly, inserts were pre-coated with 50 µg/mL human placental collagen IV (Sigma-Aldrich, Buchs, Switzerland) for 1 h at 37 °C/ 5 % CO2. For the co-culture, firstly HPECs were cultivated on the basolateral side for 2 h followed by seeding the BeWo cells on the apical side. The cells were cultivated for 3 days with medium exchange every second day.
To determine the translocation in vitro, fresh medium was given to the basolateral chambers, and 10 µg/mL or 100 µg/mL of PS particles were applied apically. Then cells were incubated for 24 h under static conditions. The transepithelial electrical resistance (TEER) of the intestinal co-culture was continuously measured during the exposure duration (24 h) via cellZscope ® device (nanoAnalytics, Germany). The TEER of the placental co-culture was measured before and after the PS exposure with a chopstick electrode (STX3, World Precision Instruments Inc., Sarasota, USA). TEER values for the cell layer were obtained by subtracting the intrinsic resistance (blank insert membrane) from the total resistance (insert membrane with cells) and
were corrected for the surface area (Ω cm 2 ). TEER values are presented as difference before and after the exposure. At the end of the exposure, apical and basolateral samples were collected for AF4 measurements in order to determine particle translocation. Samples were also taken from the applied PS working suspension and blank cell culture medium of each experiment as controls for the AF4 measurements. Membranes with intestinal and placental cells were fixed in 4 % paraformaldehyde (Sigma-Aldrich, Buchs, Switzerland) for 15 min at room temperature (RT), washed two times in phosphate buffered saline (PBS) and stored in 30 % sucrose (Sigma-Aldrich, Steinheim, Germany) at 4 °C for further immunocytochemistry staining.
Immunocytochemistry (ICC)
For ICC staining fixed cells on inserts were washed with PBS and further incubated in 0. 
Micronucleus assay
The assay was performed using black, clear-bottom, 348-well plates (PerkinElmer Inc., Waltham, USA). CHO-K1 cells were seeded at a density of 500 cells per well in 20 µL and incubated at 37 °C in 5 % CO2 for 2 h prior PS particle addition. PS particle addition was performed by adding 5 µL of growth medium including appropriate particle concentration to each well. Growth medium was exchanged after 24 h with medium containing 3 µg/mL Cytochalasin B. After 18 h media was exchanged again, using normal growth medium. Cells were fixed after one to two h of incubation in normal media using 3.8 % PFA in PBS for 20 min.
Afterwards the cells were permeabilized using 0.3 % TritonX-100 in PBS for 5 min and stained using 800 nM Hoechst 33258 in TBS-T. Image acquisition was performed on an Opera microscope (PerkinElmer Inc., USA) and analysed using Columbus 2.7.1.133403 (PerkinElmer Inc., USA).
Statistical analysis for all biological assays performed in this study
Results were generated from three independent experiments (n = 3) with a minimum of three technical replicates unless stated otherwise. The data is presented as mean with standard deviation (SD). Effects were compared to non-treated cells. Statistical analysis was done by one-way ANOVA. A values are marked by * as p < 0.05, ** as p < 0.01 and as *** as p < 0.001.
Results
In contrast to single-organ studies, this multi-endpoint study provides a consistent data set to assess the toxic potential and compare organ-specific outcomes of PS nano-and microparticles, used as representatives for NP and MP, in vitro.
Characterization of the PS-nano and PS-micro
In this study, negatively charged PS nanoparticles and microparticles were characterized by different methods. TEM images of the particles in water (Fig. 1) The surface coverage with carboxylic groups was determined to be 70 ± 10 µmol/g COOH for PS-nano and 105 ± 10 µmol/g COOH for PS-micro. 
PS-nano
Ultrapure water 36 ± 1 47 ± 1 -58.2 ± 1.1 Ham´s F12 + 10 % FCS 463 ± 4 597 ± 5 -9.9 ± 1.0
PS-micro
Toxicology studies in human GIT and placenta barrier models
Cell viability
The cell viability of the intestinal co-culture (Caco-2/HT29-MTX-E12) and placental trophoblast cells (BeWo b30) were determined for PS-nano and PS-micro in different concentrations (0.01 -100 µg/mL) by WST-1 and MTS assay, respectively. PS-nano did not affect the viability of intestinal cells up to 50 µg/mL but caused a significant (p ≤ 0.05) increase in metabolic activity at 100 µg/mL (Fig 2A) . PS-micro induced a decrease in metabolic activity only at a concentration of 0.01 µg/mL (Fig. 2B) . In the placental cell model, PS-nano induced a slight but significant (p ≤ 0.05) increase in metabolic activity at concentrations higher than 5 µg/mL ( Fig. 2C ). PS-micro increased mitochondrial activity only at concentrations from 0.01-10 µg/mL ( Fig. 2D ). 
Barrier integrity
For determining the impact of the PS particles on intestinal and placental barrier integrity, the trans-epithelial electrical resistance (TEER) was measured before and after the exposure with 10 µg/mL and 100 µg/mL PS-nano and PS-micro for 24 h, respectively. The tightness of the intestinal co-culture was not affected by PS-nano and PS-micro at both concentrations ( Fig. 3A) . Similarly, the placental co-culture exposed to PS-nano and PS-micro did not show any significant decreases in TEER values after the treatment with particles ( Fig. 3B ). 
Translocation across biological barriers
Translocation of PS-nano and PS-micro across the intestinal and placental barrier was determined by asymmetrical flow field-flow fractionation (AF4). The limit of detection (LOD) and limit of quantification (LOQ) for PS-nano and PS-micro in the different media are summarized in Table S1 .
Pre-studies verified the transport of the particles across control Transwell ® membranes without cells (Fig. S1 ). After 24 h of exposure to 10 and 100 µg/mL, PS-nano and PS-micro were detected in the apical but not in the basolateral compartment of intestinal and placental cocultures by AF4-UV analysis (Fig. 4 and 5) . 
Cellular uptake and intracellular distribution
To investigate particle uptake and intracellular distribution qualitatively, intestinal and placental co-cultures exposed to particles for 24 h were stained for nuclei and actin filaments and characterized by confocal laser scanning microscopy (CLSM). In contrast to untreated controls ( Fig. 6A and D) , PS-nano and PS-micro were internalized by intestinal and placental cells ( Fig.   6B-F) . For the placental co-cultures, uptake was only apparent in the BeWo b30 trophoblast cells on the apical side of the insert but not in HPEC-A2 endothelial cells cultivated on the basolateral side ( Fig 6E2 and F2) . Particles were not homogenously distributed in the cell layers but were found in single spots of the samples. Presented images are representative for all investigated samples.
Embryotoxicity
To understand the embryotoxic potential of PS-nano and PS-micro, the embryonic stem cell (ESC) assasy was performed. The ESC test assesses three endpoints: cytotoxic effects on NIH/3T3 fibroblasts and mouse embryonic stem cells (mES-D3) as well as the inhibition of the differentiation into beating cardiomyocytes (Seiler and Spielmann, 2011) . Embryotoxicity is identified as a relation of the corresponding IC50 and ID50 values. The IC50 value of PS-nano for NIH/3T3 fibroblasts and mES-D3 could not be determined because they were not toxic in the tested concentration range (0.01 -100 µg/mL) ( Fig. 7A and B) . For PS-micro, the IC50 was 12.6 µg/mL for NIH/3T3 cells and mES-D3 ( Fig. 7 A, B and D) . In the case of mES cells, the IC50 for PS-nano was higher than 100 µg/mL and therefore not identified in the tested concentration range. The differentiation into beating cardiomyocytes was inhibited at a dose of 89.9 µg/mL PS-nano and 0.1 µg/mL PS-micro (ID50) ( Fig. 7 C and D) . Overall, the classification calculated according to Seiler and Spielmann resulted in weak embryotoxicity of the investigated PS-nano and -micro ( Fig. 7 D) (Seiler and Spielmann, 2011) . This classification is a result of the slightly higher effect on differentiation (lower ID50) compared to the toxicity of the tested material. 
Genotoxicity
As genotoxicity is a critical factor in our toxicity assessment, we used two different assays to analyse different pathways. The p53 reporter gene assay was performed to check for p53 activation, as it is based on the promotor of a major downstream target of activated p53, CDKN1A, which drives the expression of DsRed2 in this biosensor. Alternatively, we also checked for particle-induced DNA double-strand breaks by a micronucleus assay.
p53 expression
For the detection of possible genotoxic effects of PS-nano and -micro, cells were imaged every two hours for 48 h, and fluorescence intensity was integrated. At higher concentrations (>100 µg/mL for PS-nano and > 25 µg/mL for PS-micro), the particles interfered with the assay due to their fluorescent labelling, and therefore they were excluded from the analysis. The expression level induced by colchicine was used to identify a genotoxic compound or particle and served as positive control. As neither PS-nano nor PS-micro did reach this activation level, these particles were non-genotoxic at the indicated concentration ( Fig. 8A and B) . Area under the curve of cells exposed to different concentrations of PS-nano (A) or PS-micro (B) for 5 days. 62.5 nM colchicine was used as positive control (expression level indicated by a horizontal line).
Data represent mean ± SD of three independent measurements. ** p ≤ 0.01 compared to untreated cells.
Micronuclei formation
In addition, genotoxicity was analysed using a protocol adapted from the OECD protocol 487 (Aardema et al., 2006) . This micronucleus assay is ideally suited to identify aneugens and clastogens and was validated at different laboratories, resulting in a high degree of confidence in the generated data. No genotoxicity was observed in the micronucleus assay ( Fig. 9,   Fig. S2 ), which is in line with the data generated using the reporter gene assay. 
Discussion
Burns and Boxall (2018) conclude in their review that one missing aspect in the field of NP and MP research is their effect characterization. Effect studies are needed on the types of MP that occur in the environment and on their transformation products, such as NP (Burns and Boxall, 2018) . Our study tries to address this knowledge gap by evaluating the impact of PS-nano and PS-micro on different key endpoints of acute toxicity in vitro, including assays relevant to highly sensitive populations such as the developing embryo (i.e., placental transfer and embryonic stem cell assay).
PS particles with sizes of 0.5 µm and 50 nm were used as representatives for MP and NP, respectively. The primary size of the particles obtained from TEM measurements did not change in the different media as confirmed by AF4-UV-MALS analysis indicating that different media compositions and supplements did not have a strong influence on particle agglomeration. Besides size, surface charge and functionalization with ligands can play a decisive role in the uptake mechanisms and toxicity profile of particles (Chiu et al., 2015; Fischer et al., 2003; Tenzer et al., 2013) . For instance, Asati et al. 2011 described that positively charged and neutral cerium oxide nanoparticles were preferentially taken up by human cells in comparison to negatively charged particles and were recovered in different cell compartments depending on their surface charge (Asati et al., 2011 (Asati et al., , 2010 . Similarly, the pulmonary toxicity of stearylamine-polylactic acid (PLA) polymers in mice was higher for positively than negatively charged particles, due to enhanced cellular uptake and localisation of cationic particles in the lung (Harush-Frenkel et al., 2010) . The PS particles used in this study were functionalized with carboxyl groups (COOH). The surface charge of PS-nano and -micro were similar and slightly negative in the different media, which can be explained by the fact that proteins (mainly the BSA) contained in the fetal calf serum are forming a protein corona around the particles dominating the overall charge of the particles (Kloet et al., 2015) .
Nevertheless, differences may exist in the density or type of protein coating between PS-nano and -micro, which could affect particle adhesion, uptake and subsequent biological responses by the cells.
The mass production of MP and the breakdown products of meso-scaled plastic inevitably results in an increase of MP release into the environment with currently unknown consequences. Presently, there are no factual data, only few probabilistic material flow model data (Adam et al., 2018; Kawecki et al., 2018) , on concentrations in the environment and certainly none on their physicochemical forms or distribution (Burns and Boxall, 2018) .
Published quantitative research on uptake and accumulation of plastics by the organisms is scarce. Therefore, we have chosen a wide range of concentrations in our study (0.01 µg/mL -100 µg/mL) to cover potential low as well as high, worst-case exposure scenarios. The food chain is considered the main entry path for NP and MP into the human body (Fernandes et al., 2007) . In order to assess whether PS-nano and PS-micro penetrate the human intestinal barrier, we performed translocation and effect studies on intestinal in vitro co-cultures. In case of particle transfer to the systemic circulation, we chose the placenta as a secondary organ of interest since it is highly perfused and acts as an essential barrier to protect the developing fetus. The intestinal co-cultures were largely unaffected by PS-nano and -micro regarding their metabolic activity in the tested concentration range from 0-100 µg/mL. The phenomenon that lower doses could be more toxic than higher doses has been previously described (Vandenberg et al., 2012) but it remains to be shown if intestinal functionality and integrity is compromised. Since we did neither observe a decrease in TEER or an increased translocation of PS-micro, it appears that intestinal barrier function was still intact. A different metabolic response was observed for placental trophoblasts. Here, a moderate increase in mitochondrial activity was induced by PS-nano at concentrations higher than 5 µg/mL and at 0.01-10 µg/mL for PS-micro. The consequences of this increased mitochondrial activity remain to be investigated, but again, we did not observe any adverse effects on barrier integrity as TEER and PS particle translocation was not affected at all concentrations. Clearly, our study shows that different cell types react differently to the exposure to PS-nano and -micro. One reason for the different responses in intestinal and placental cells might be the robustness of the tissue types and the mucus layer, which has a protective function and is present on the upper side of the intestinal cultures but absent in placental trophoblast cultures (Drasler et al., 2017; Wright and Kelly, 2017 (Grafmueller et al., 2015; Wick et al., 2010) and in different intestinal in vitro models (Schimpel et al., 2014; Walczak et al., 2015) . However, consistent with our findings, the transfer was highly limited for carboxyl-modified PS nanoparticles in perfused placentas (Grafmueller et al., 2015) and in intestinal in vitro models where mucus-producing cells were present (Schimpel et al., 2014) . Interestingly, two commercial 50 nm PS-nanoparticles with similar size and surface charge showed completely different transport behaviour across the BeWo b30 transfer model with very low resp. high permeability in a previous study (Kloet et al., 2015) . In intestinal in vitro models, the translocation of PS nanoparticles was strongly influenced not only by size but also by the surface chemistry, where two types of negatively charged 50 nm nanoparticles showed an over 30-fold difference in translocation rate. A neutral surface charge significantly reduced the translocation rate, whereas negatively charged particles significantly increased in translocation rate . The choice of the intestinal in vitro model (mono-, co-culture or triple-culture) plays another important role, since the presence of goblet cells or M-cells can affect the translocation of particles . Non-functionalized 200 nm-polystyrene particles could be shown to permeate the mucus layer and penetrate better into the epithelium, than smaller particles (Teubl et al., 2013) .
For these reasons, further studies using a larger variety of plastic particles with distinct properties are needed to better understand the potential placental and intestinal transfer of MP and NP.
Despite the absence of intestinal and placental translocation, confocal microscopy showed that nano-and micron-sized PS particles were internalized by intestinal and placental cells where they may accumulate and elicit potential adverse long-term effects to barrier function. It was not possible to conclude if uptake of a specific particle was higher in intestinal vs. placental cocultures since these experiments were performed in different labs with slightly different equipment and settings. Also, quantitative comparisons between PS-nano and PS-micro internalization in the same co-culture was challenging since the different particles have distinct fluorescence intensities. Higher fluorescence of larger PS-micro particles could, therefore, be misinterpreted as higher uptake and PS-nano may only be detectable if they accumulate in vesicles.
Because the PS particles were taken up by placental co-cultures and may eventually cross the barrier upon prolonged exposure as well as previously described placental transfer of another type of 50 nm COOH-PS nanoparticles (Kloet et al., 2015) , we performed further investigations on the embryotoxicity of PS-nano and PS-micro. Using mice embryos at the two-cell stage Bosman et al. found no embryotoxicity using a mixture of PS nanoparticles in the size of 40 nm to 120 nm at a concentration of 11 million particles per mL (Bosman et al., 2005) . Although the EST assay is based on mouse stem cells, we found weak embryotoxicity of our PS-nano and -micro. In general, the EST assay is widely accepted (Campagnolo et al., 2013) and showed developmental toxicity for other particle types similar to what is reported in this study. This is the case for single-wall carbon nanotubes (Pietroiusti et al., 2011) , cobalt ferrite nanoparticles coated with silanes and gold nanoparticles coated with hyaluronic acid (Di Guglielmo et al., 2010) . Interestingly, silica nanoparticles had a stronger effect on development in the EST assay when smaller sizes were used, which is contrary to our findings (Park et al., 2009 ). Due to the environmental burden of nanoparticles, different studies investigated the effect on aquatic organisms. Asharani et al. found defects in cardiac development of zebrafish after exposure to silver and platinum, but not gold particles (Asharani et al., 2011) . Della Torre et al., 2014 found no embryotoxicity for PS nanoparticles with carboxyl modification up to 50 µg/mL in sea urchin embryos (Della Torre et al., 2014) .
Assessment of genotoxicity is another sensitive and essential parameter to address the toxic potential of nano-and microparticles. We concentrated on two cellular assays (p53 reporter gen assay and micronucleus assay) since the bacterial AMES test may not be suitable to assess the mutagenicity of nanosized materials (Clift et al., 2013; Drasler et al., 2017) . They additionally suggest delaying the co-treatment with Cytochalasin-B (Cyt-B), which we did by implementing a 24 h co-culture period of PS-nano and PS-micro with cells prior to Cyt-B treatment. The micronucleus assay detects chromosome breakage and spindle interference, both leading to the formation of micronuclei. In line with our findings of an unaffected rate of micronuclei formation, previous studies also report no interference of COOH-PS-nano up to 5 µg/mL with the spindle apparatus (Liu et al., 2011) . As genotoxicity can occur by several different pathways and mechanisms, an additional assay (p53 reporter gen assay) to identify DNA damaging factors was implemented. Nanomaterials can indirectly cause DNA damage through the generation of reactive oxidative species, a case especially often reported for metalcontaining nanoparticles (E. . But, also nanoparticle coating can be attributed to DNA damage (Makama et al., 2018) . Della Torre et al., 2014 found no p38 activation for PS nanoparticles with COOH surface modification, whereas NH2-modified PS nanoparticles induced genotoxicity (Della Torre et al., 2014) . Another aspect to DNA damage induction by PS-nano and PS-micro is the adsorption of mutagens due to their large relative surface area. It has been shown that PS nanoparticles could effectively bind hydrocarbons, many of them being classified as mutagens, under realistic in vivo conditions (Liu et al., 2016) .
Although this aspect was beyond the scope of the current study, it highlights the relevance of genotoxicity assays using PS-nano and PS-micro.
In contrast to a single-organ study, the presented data on the effect of exactly the same type of PS-nano and PS-micro on multiple key endpoints in vitro provides a consistent data-set to compare organ-specific responses. This multi-organ, multi-endpoint study brings a great benefit to a more precise hazard assessment than investigating only one endpoint or one organ.
Conclusion
For a proper risk analysis of the emerging NP and MP, valid data for both, exposure and hazard, are needed. Our study presents a multi-organ and multi-endpoint toxicological assessment of PS nano-and microparticles. The results of our study bring a high added value in the field of MP bio-responses in humans and contribute to a better understanding of the potential mechanisms induced by NP and MP. This study gathered essential knowledge on the interaction, accumulation, translocation and specific effects caused by NP and MP in different tissues. Our study highlights that it is important to assess each tissue /cell type individually since the same material can induce distinct effects in different tissues. Thus, a combination of different assays, as well as specific standardized protocols for testing of plastics are needed for a more powerful predictive toxicological assessment of NP and MP in humans.
Despite the fact that only minor acute toxic effects were observed in this study, there is still a need for further investigations of long-term effects of NP and MP. A better understanding of the relationships between translocation mechanisms and particle sizes would contribute very much to the risk evaluation of NP and MP in the environment.
